Identifying metabolic factors associated with critical disease can help to improve management of patients hospitalized for coronavirus disease 2019 (COVID-19). High triglycerides and low HDL levels characterize the atherogenic dyslipidemia closely related to insulin resistance and diabetes. We examined associations of atherogenic dyslipidemia detected on admission with outcome of COVID-19 during hospitalization.
Bellia, A., Andreadi, A., Giudice, L., De Taddeo, S., Maiorino, A., D'Ippolito, I., et al. (2021). Atherogenic dyslipidemia on admission is associated with poorer outcome in people with and without diabetes hospitalized for COVID-19. DIABETES CARE, 44(9), 2149-2157 [10.2337/dc20-2838].
Atherogenic dyslipidemia on admission is associated with poorer outcome in people with and without diabetes hospitalized for COVID-19
Bellia, Alfonso;Andreadi, Aikaterini;Romano, MariaMembro del Collaboration Group
;Magrini, Andrea;Di Daniele, Nicola;Rogliani, Paola;Lauro, Davide
2021-01-01
Abstract
Identifying metabolic factors associated with critical disease can help to improve management of patients hospitalized for coronavirus disease 2019 (COVID-19). High triglycerides and low HDL levels characterize the atherogenic dyslipidemia closely related to insulin resistance and diabetes. We examined associations of atherogenic dyslipidemia detected on admission with outcome of COVID-19 during hospitalization.| File | Dimensione | Formato | |
|---|---|---|---|
|
2021-diabetes care-COVID.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
894.17 kB
Formato
Adobe PDF
|
894.17 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
